Send me a link:

*Text messaging rates may apply.

 Dow Up 0.05% Nasdaq Up 0.18%

More On ACU.AX

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Acuvax Limited (ACU.AX)

-ASX
0.20 0.00(0.00%) Mar 20
Prev Close:0.20
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.20 - 0.20
52wk Range:0.00 - 0.20
Volume:0
Avg Vol (3m):0
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Headlines

  • No Headlines available for ACU.AX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acuvax Limited, through its subsidiaries, primarily engages in the research and development of cancer therapies in Australia and North America. It is also involved in the development of virus and vaccines. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback